查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541620

2024-2032 年按產品（連網感測器、整合連網設備）、最終用戶（醫院和醫療保健提供者、家庭護理）、技術（藍牙、NFC 等）和區域分類的聯網給藥設備市場報告

Connected Drug Delivery Devices Market Report by Product (Connected Sensors, Integrated Connected Devices), End User (Hospitals and Healthcare Providers, Homecare), Technology (Bluetooth, NFC, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球連網給藥設備市場規模達到8.644億美元。對遠端監控和遠距醫療的需求、人口老化以及慢性阻塞性肺病（COPD）發病率的增加是推動市場成長的一些關鍵因素。

連網給藥設備市場分析：

主要市場促進因素：改善病患治療結果和醫療管理成本的需求不斷增加。

主要市場趨勢：對家庭照護的日益偏好和慢性病數量的增加提供了有利的市場前景。

地理趨勢：由於強大的醫療基礎設施和持續的技術創新，北美佔據了最大的市場佔有率。

競爭格局：連網給藥設備產業的一些主要市場參與者包括 Aderium Ltd.、BioCorp Production、Cohero Health Inc. (AptarGroup Inc.)、Elcam Medical ACS。有限公司、芬達航空有限公司z oo、Merck KGaA、Phillips Medisize (Molex LLC)、Propeller Health (Resmed Inc.)、Teva Pharmaceutical Industries Ltd. 和 West Pharmaceutical Services Inc. 等。

挑戰與機會：雖然市場面臨病患治療資料安全問題等挑戰，這會影響市場，但在維護電子健康記錄（EHR）方面也遇到了機會。

連網給藥設備市場趨勢：

人口老化加劇

隨著人們年齡的成長，他們患糖尿病、高血壓和心血管疾病等持續疾病的風險更大。連接的藥物傳輸設備透過確保精確的藥物劑量和監測，在有效處理這些情況方面發揮重要作用。此外，這些設備可以透過提醒、追蹤劑量以及將記錄機械地傳輸給醫療保健公司來簡化這些治療方案。連接的藥物傳輸設備可以遠端追蹤藥物依從性和健康參數。這使得醫療保健公司能夠及早干預問題，從而支持就地老化。世界衛生組織（WHO）網站上發表的一篇文章顯示，到2050年，全球60歲以上的人口預計將增加一倍，達到近21億。

慢性阻塞性肺病（COPD）盛行率上升

根據世界衛生組織（WHO）網站2023年更新的內容，近90%的70歲以下慢性阻塞性肺病死亡發生在低收入和中等收入國家。慢性阻塞性肺病患者需要精確、可控制的藥物輸送，其中包括支氣管擴張劑和皮質類固醇。連接的藥物傳輸設備可確保正確劑量和及時給藥，這對於有效應對慢性阻塞性肺病症狀至關重要。此外，連接的設備可以監控吸入策略並向患者提供即時回饋。這使得慢性阻塞性肺病患者能夠最佳化他們的吸入方法，確保他們從藥物中獲得最大的益處。與此一致的是，慢性阻塞性肺病是一種革命性的疾病，需要持續監測症狀和肺功能。連接設備可遠端監測慢性阻塞性肺病患者的健康狀況，包括肺部特徵測試和症狀監測，有助於及早發現病情加重並及時調整治療計劃。

蓬勃發展的遠距醫療產業

IMARC Group的報告顯示，2023年全球遠距醫療市場規模將達到747億美元。連接的藥物輸送設備透過允許即時追蹤患者的藥物依從性、治療反應和健康狀態來補充遠距醫療。這種持續監測有利於糖尿病、高血壓和呼吸道疾病等疾病的持續疾病管理。此外，連網的藥物傳輸設備可以與遠距醫療結構相結合，使醫療保健公司能夠遠端改變藥物劑量、提供客製化的護理計劃並監測人員的發展。這種整合透過直接使用來自患者家中的可操作統計數據和見解，提高了遠距醫療諮詢的效能和有效性。

連網給藥設備市場細分：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、最終用戶和技術對市場進行了分類。

按產品分類：

連接的感測器

連接的吸入器感測器

可連接的注射感測器

整合連接設備

連接的吸入設備

連接的注射設備

連網感測器佔據大部分市場佔有率

該報告根據產品提供了詳細的市場細分和分析。這包括連接的感測器（連接的吸入器感測器、可連接的注射感測器）和整合的連接設備（連接的吸入設備、連接的注射設備）。根據該報告，連接感測器代表了最大的部分。

連接的感測器可實現即時追蹤和事實收集，使醫療保健提供者能夠遠端追蹤患者對藥物治療方案和生理反應的依從性。這種程度的連結透過保證及時干預和隨後的修改來提高治療品質。此外，連接的感測器增強了患者對治療過程的高效和有效的參與和參與。隨著個人化醫療的需求不斷成長，配備感測器的連網給藥設備可以提供有關患者健康指標的寶貴見解，提高治療效率並降低與不依從或次優治療併發症相關的醫療成本。

按最終用戶分類：

醫院和醫療保健提供者

居家護理

醫院和醫療保健提供者佔據行業最大佔有率

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院和醫療保健提供者以及家庭護理。報告稱，醫院和醫療保健提供者佔據了最大的市場佔有率。

醫院和醫療保健提供者優先考慮病患照護和安全，透過實現精確藥物管理和監控的連網設備可以顯著增強病患照護和安全。連接的藥物傳輸設備提供有關患者依從性、劑量準確性和治療有效性的即時資料，從而改善臨床結果並減少錯誤。此外，由於工作效率和資源利用率提高，醫療保健提供者對數位健康解決方案的使用正在增加。智慧型設備與電子病歷和其他醫院軟體和平台配合使用，使它們能夠無縫共享資料並提高醫院的生產力。

按技術分類：

藍牙

近場通訊

其他技術

藍牙代表了領先的細分市場

該報告基於該技術對市場進行了詳細的細分和分析。這包括藍牙、NFC 和其他技術。根據該報告，藍牙是最大的細分市場。

支援藍牙的小工具可以更輕鬆地與智慧型手機和平板電腦整合，使患者能夠透過方便用戶使用的介面和行動應用程式有效地控制自己的健康狀況。藍牙連接的舒適性和可靠性有助於連接藥物輸送設備的增加，因為醫療保健供應商正在尋求利用虛擬健身解決方案來提高患者參與度和治療依從性。除此之外，透過將藍牙連接整合到藥物輸送設備中，主要參與者可以提供更強大的功能，例如遠端監控、事實系列以及與醫療保健營運商和患者的即時口頭交流。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的連網給藥設備市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。該報告稱，北美是連網給藥設備最大的區域市場。

根據醫療保險和醫療補助服務中心網站 2023 年更新的內容，2022 年美國醫療保健支出成長 4.1%，達到 4.5 兆美元，即人均 13,493 美元。醫療保健支出的增加反映出人們更加重視透過創新技術改善患者的治療結果並降低整體醫療保健成本。北美擁有大量製藥公司和醫療設備製造商，它們大力投資連網給藥設備的研發 (R&D) 活動。這些公司正在利用物聯網 (IoT) 和數位連接的進步來開發創新設備，以增強藥物依從性、患者監測和整體治療結果。此外，該地區有利的報銷政策和支持性監管框架也有助於該細分市場的快速成長。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。連網藥物輸送設備產業的一些主要市場參與者包括 Aderium Ltd.、BioCorp Production、Cohero Health Inc. (AptarGroup Inc.)、Elcam Medical ACS。有限公司、芬達航空有限公司z oo、Merck KGaA、Phillips Medisize (Molex LLC)、Propeller Health (Resmed Inc.)、Teva Pharmaceutical Industries Ltd. 與 West Pharmaceutical Services Inc.

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

主要參與者不斷改進感測器技術、連接解決方案和行動健康應用程式，以增強連網藥物輸送設備的功能、可靠性和用戶體驗。他們還將連網給藥設備與數位健康平台和電子病歷 (EMR) 整合，以促進無縫資料交換、即時監控和個人化醫療介入。此外，許多公司正在開發方便用戶使用的介面、行動應用程式和教育資源，以提高患者的參與度、治療方案的依從性以及慢性病的自我管理。他們也正在開發支援個人化醫療方法的連網藥物輸送設備，例如基於即時資料和患者特定健康資訊的劑量調整。例如，2023年，領先的科技公司默克與BenevolentAI和Exscientia合作，加強人工智慧驅動的藥物發現。

連網給藥設備市場新聞：

2024 年 5 月 24 日：呼吸電子健康、遠端監控和資料管理解決方案領域的領導者 Aderium Limited 宣布，阿斯特捷利康已選擇其 Hailie(R) Smartinhaler(R) 平台進行臨床試驗。該合約為期三年，價值 110 萬美元。

2023 年 6 月 6 日：諾和諾德以 1.54 億歐元收購醫療設備製造商 Biocorp。

本報告回答的關鍵問題：

  • 迄今為止，全球連網給藥設備市場表現如何，未來幾年將如何表現？
  • 全球市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的市場？
  • 基於產品的市場區隔是什麼？
  • 連網給藥設備市場中哪種產品最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 連網給藥設備市場中哪一個是最具吸引力的最終用戶？
  • 基於技術的市場區隔是什麼？
  • 聯網給藥設備市場中哪一項技術最具吸引力？
  • 市場按地區分類是怎樣的？
  • 連網給藥設備市場中哪個區域最具吸引力？
  • 市場競爭結構如何？
  • 全球連網給藥設備市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球連網給藥設備市場表現如何，未來幾年將如何表現？
  • 全球市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的市場？
  • 基於產品的市場區隔是什麼？
  • 連網給藥設備市場中哪種產品最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 連網給藥設備市場中哪一個是最具吸引力的最終用戶？
  • 基於技術的市場區隔是什麼？
  • 聯網給藥設備市場中哪一項技術最具吸引力？
  • 市場按地區分類是怎樣的？
  • 連網給藥設備市場中哪個區域最具吸引力？
  • 市場競爭結構如何？
  • 全球連網給藥設備市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球連網給藥設備市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 連接的感測器
    • 市場趨勢
    • 關鍵環節
      • 連接的吸入器感測器
      • 可連接的注射感測器
    • 市場預測
  • 整合連接設備
    • 市場趨勢
    • 關鍵環節
      • 連接的吸入設備
      • 連接的注射設備
    • 市場預測

第 7 章：市場區隔：按最終用戶

  • 醫院和醫療保健提供者
    • 市場趨勢
    • 市場預測
  • 居家護理
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依技術

  • 藍牙
    • 市場趨勢
    • 市場預測
  • 近場通訊
    • 市場趨勢
    • 市場預測
  • 其他技術
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Adherium Limited
    • BioCorp Production
    • Cohero Health Inc. (AptarGroup Inc.)
    • Elcam Medical ACS. Ltd
    • Findair Sp. z oo
    • Merck KGaA
    • Phillips Medisize (Molex LLC)
    • Propeller Health (Resmed Inc.)
    • Teva Pharmaceutical Industries Ltd.
    • West Pharmaceutical Services Inc.
Product Code: SR112024A3738

The global connected drug delivery devices market size reached US$ 864.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,879.9 Million by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032. The demand for remote monitoring and telemedicine, rising aging population, and increasing occurrence of chronic obstructive pulmonary disease (COPD) are some of the key factors strengthening the growth of the market.

Connected Drug Delivery Devices Market Analysis:

Major Market Drivers: There is a rise in demand for improved patient treatment outcomes and cost of medical management.

Key Market Trends: The growing preferences for home-based care and increasing number of chronic diseases are offering a favorable market outlook.

Geographical Trends: North America holds the largest segment because of strong healthcare infrastructure and ongoing innovations in technology.

Competitive Landscape: Some of the major market players in the connected drug delivery devices industry include Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc., among many others.

Challenges and Opportunities: While the market faces challenges like concerns about patient treatments data security, which impacts the market, it also encounters opportunities in maintaining electronic health records (EHR).

Connected Drug Delivery Devices Market Trends:

Growing aging population

As people are aging, they are encountering greater risk of continual ailments like diabetes, high blood pressure, and cardiovascular diseases. Connected drug delivery devices play an important role in handling those situations effectively by ensuring precise medicinal drug dosing and monitoring. Moreover, these devices can simplify those regimens through reminders, tracking dosages, and transmitting records mechanically to healthcare companies. Connected drug delivery devices allow remote tracking of medicine adherence and fitness parameters. This allows healthcare companies to intervene the issues early, thus supporting aging in place. An article published on the website of the World Health Organization (WHO) shows that individuals aged over 60 are expected to double by 2050, reaching nearly 2.1 billion worldwide.

Rising prevalence of chronic obstructive pulmonary disease (COPD)

As per the content updated in 2023 on the website of the World Health Organization (WHO), nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries. COPD patients require precise and managed delivery of medicinal drugs which include bronchodilators and corticosteroids. Connected drug delivery devices ensure correct dosing and timely administration, which is vital for coping with COPD signs effectively. In addition, connected devices can monitor inhalation strategies and provide feedback to patients in actual-time. This allows COPD sufferers optimize their inhalation approach, making sure that they obtain the maximum benefits from their medicines. In line with this, COPD is a revolutionary disease that requires continuous monitoring of symptoms and lung function. Connected devices permit for remote monitoring of COPD patients' fitness fame, consisting of lung feature tests and symptom monitoring, facilitating early detection of exacerbations and timely adjustments to treatment plans.

Thriving telemedicine sector

The IMARC Group's report shows that the global telemedicine market reached US$ 74.7 Billion in 2023. Telemedicine platforms facilitate remote consultations between healthcare providers and patients. Connected drug delivery devices supplement telemedicine by allowing actual-time tracking of patients' medication adherence, treatment response, and fitness status. This ongoing monitoring is beneficial for continual sickness management in conditions like diabetes, high blood pressure, and respiratory illnesses. Additionally, connected drug delivery devices can be incorporated with telehealth structures, permitting healthcare companies to remotely alter medicine dosages, provide customized care plans, and monitor person development. This integration improves the performance and effectiveness of telemedicine consultations by using actionable statistics and insights directly from the patient's home.

Connected Drug Delivery Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, end user, and technology.

Breakup by Product:

Connected Sensors

Connected Inhaler Sensors

Connectable Injection Sensors

Integrated Connected Devices

Connected Inhalation Devices

Connected Injection Devices

Connected sensors accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes connected sensors (connected inhaler sensors, connectable injection sensors) and integrated connected devices (connected inhalation devices, connected injection devices). According to the report, connected sensors represent the largest segment.

Connected sensors enable real-time tracking and facts collection, permitting healthcare providers to remotely track patient adherence to medicinal drug regimens and physiological responses. This level of connectivity improves the quality of treatment by guaranteeing timely interventions and subsequent modification. In addition, connected sensors enhance efficient and effective patient engagement and involvement in their treatment processes. As the demand for personalized medicine is growing, connected drug delivery devices equipped with sensors provide valuable insights into patient health metrics, improving treatment efficiency and reducing healthcare costs associated with complications from non-adherence or suboptimal therapy.

Breakup by End User:

Hospitals and Healthcare Providers

Homecare

Hospitals and healthcare providers hold the largest share of the industry

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and healthcare providers and homecare. According to the report, hospitals and healthcare providers account for the largest market share.

Hospitals and healthcare providers prioritize patient care and safety, which are significantly enhanced by connected devices that enable precise medication administration and monitoring. Connected drug delivery devices offer real-time data on patient adherence, dosage accuracy, and treatment effectiveness, thereby improving clinical outcomes and reducing errors. Furthermore, the use of digital health solutions by the healthcare providers is rising because of better efficiency of work and utilization of resources. Smart devices work with EHRs and other hospital software and platforms, allowing them to share data seamlessly and improve the productivity of the hospital.

Breakup by Technology:

Bluetooth

NFC

Other Technologies

Bluetooth represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes Bluetooth, NFC, and other technologies. According to the report, Bluetooth represents the largest segment.

Bluetooth-enabled gadgets facilitate easier integration with smartphones and tablets, empowering patients to control their health effectively via user-pleasant interfaces and mobile apps. The comfort and reliability of Bluetooth connectivity is assisting the increase of connected drug delivery devices, as healthcare vendors are looking to leverage virtual fitness solutions for higher patient engagement and treatment adherence. Besides this, by means of integrating Bluetooth connectivity into drug delivery devices, key players can provide greater functionalities like remote monitoring, facts series, and real-time verbal exchange with healthcare carriers and patients.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest connected drug delivery devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for connected drug delivery devices.

As per the content updated in 2023 on the website of Centers for Medicare & Medicaid Services, U.S. health care spending grew 4.1 percent in 2022, reaching $4.5 trillion or $13,493 per person. The increasing healthcare expenditure reflects a greater emphasis on improving patient outcomes and reducing overall healthcare costs through innovative technologies. North America has a strong presence of pharmaceutical companies and medical device manufacturers that are investing heavily in research and development (R&D) activities of connected drug delivery devices. These companies are leveraging advancements in Internet of Things (IoT) and digital connectivity to develop innovative devices that enhance medication adherence, patient monitoring, and overall treatment outcomes. Furthermore, favorable reimbursement policies and supportive regulatory frameworks in the region contribute to the rapid growth of this market segment.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the connected drug delivery devices industry include Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players continuously improving sensor technology, connectivity solutions, and mobile health applications to enhance the functionality, reliability, and user experience of connected drug delivery devices. They are also integrating connected drug delivery devices with digital health platforms and electronic medical records (EMRs) to facilitate seamless data exchange, real-time monitoring, and personalized healthcare interventions. Moreover, many companies are developing user-friendly interfaces, mobile apps, and educational resources to enhance patient engagement, adherence to treatment regimens, and self-management of chronic conditions. They are also developing connected drug delivery devices that support personalized medicine approaches, such as dose adjustments based on real-time data and patient-specific health information. For instance, in 2023, Merck, a leading science and technology company collaborated with BenevolentAI and Exscientia to strengthen AI-driven drug discovery.

Connected Drug Delivery Devices Market News:

May 24, 2024: Adherium Limited, a leader in respiratory eHealth, remote monitoring and data management solutions, announced that AstraZeneca has selected its Hailie(R) Smartinhaler(R) platform for a clinical trial. This contract is valued at $1.1M over the course of three years.

June 6, 2023: Novo Nordisk acquired medical device manufacturer Biocorp for €154 million.

Key Questions Answered in This Report:

  • How has the global connected drug delivery devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the connected drug delivery devices market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the connected drug delivery devices market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the connected drug delivery devices market?
  • What is the breakup of the market based on the region?
  • Which is the most attractive region in the connected drug delivery devices market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global connected drug delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Connected Drug Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Connected Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Connected Inhaler Sensors
      • 6.1.2.2 Connectable Injection Sensors
    • 6.1.3 Market Forecast
  • 6.2 Integrated Connected Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Connected Inhalation Devices
      • 6.2.2.2 Connected Injection Devices
    • 6.2.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Healthcare Providers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Homecare
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Bluetooth
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 NFC
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Other Technologies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BioCorp Production
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Cohero Health Inc. (AptarGroup Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Elcam Medical ACS. Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Findair Sp. z o. o.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Phillips Medisize (Molex LLC)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Propeller Health (Resmed Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 West Pharmaceutical Services Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Connected Drug Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Connected Drug Delivery Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Connected Drug Delivery Devices Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Connected Drug Delivery Devices Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Connected Drug Delivery Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Connected Drug Delivery Devices (Connected Sensors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Connected Drug Delivery Devices (Connected Sensors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Connected Drug Delivery Devices (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Connected Drug Delivery Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Connected Drug Delivery Devices (Bluetooth) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Connected Drug Delivery Devices (Bluetooth) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Connected Drug Delivery Devices (NFC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Connected Drug Delivery Devices (NFC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Connected Drug Delivery Devices (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Connected Drug Delivery Devices (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Connected Drug Delivery Devices Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Connected Drug Delivery Devices Industry: SWOT Analysis
  • Figure 72: Global: Connected Drug Delivery Devices Industry: Value Chain Analysis
  • Figure 73: Global: Connected Drug Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Connected Drug Delivery Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Connected Drug Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Connected Drug Delivery Devices Market: Competitive Structure
  • Table 7: Global: Connected Drug Delivery Devices Market: Key Players